PedAM
Pediatric Disease Annotations & Medicines
| Disease | sensorineural hearing loss |
| Phenotype | C0029882|otitis media |
| Sentences | 8 |
| PubMedID- 20336821 | Objective: to clarify true incidence of sensorineural hearing loss in ears with chronic otitis media (com). |
| PubMedID- 24125189 | Conclusions: risk factors for sensorineural hearing loss (snhl) development in patients with chronic otitis media (com) are longer duration of disease, older age and the presence of cholesteatoma. |
| PubMedID- 25741670 | Higher risk of developing sudden sensorineural hearing loss in patients with chronic otitis media. |
| PubMedID- 22397217 | Objectives: we describe the symptom complex and management of a clinical entity we refer to as "pseudo-sudden deafness," which is an episode of acute otitis media that leads to sensorineural hearing loss with reduced speech discrimination. |
| PubMedID- 24347479 | Conclusions: vegf has an important role in vestibular schwannomas, otitis media with effusion, and sensorineural hearing loss. |
| PubMedID- 23449378 | sensorineural hearing loss in patients with chronic suppurative otitis media. |
| PubMedID- 23113377 | Results: included patients had a mean age of 12.9 years; nine had chronic suppurative otitis media with cholesteatoma; six sensorineural hearing loss; six chronic perforation of the tympanic membrane; and one each with conductive hearing loss, facial paralysis, neurological impairment after intracranial complications, and complications of surgery. |
| PubMedID- 20556589 | Our study investigated the neurotoxicity of quinolinic acid (qa) to spiral ganglion cells (sgcs), observed the protective effects of n-methyl-d-aspartate (nmda) receptor antagonist mk-801 and magnesium ions on the qa-induced injury to sgcs, and analyzed the role of qa in otitis media with effusion (ome)-induced sensorineural hearing loss (snhl). |
Page: 1